Revenue from its MuCell Extrusion (MEL) technology licensing business is expected to be at similar levels to the first six months of 2013.
The company said recent technical innovations at MEL have shown promising results in foaming a variety of polymers outside the technology’s core focus on the consumer packaging market. In order to exploit these innovations while maintaining its focus on existing product and markets, the company plans to develop further expertise at its Croydon, UK site.
